As the currently largest descriptive study of MLS and ChAc patients in China, our research expands on the clinical and genetic spectrum of XK and VPS13A, contributing to the clinical diagnosis of MLS and ChAc. This evidence concerns the gene XK and McLeod neuroacanthocytosis syndrome.